SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2017

Financial information for the company’s segments is as follows.

	Three months ended
	March 31,
(in millions)	2017		2016
Net sales
Renal	$	896	$	898
Hospital Products		1,579		1,477
Total net sales	$	2,475	$	2,375
EBITDA
Renal	$	199	$	122
Hospital Products		564		509
Total segment EBITDA	$	763	$	631

	March 31,		December 31,
(in millions)	2017		2016
Total assets
Renal	$	4,506	$	4,315
Hospital Products		6,466		6,407
Total assets	$	10,972	$	10,722

EBITDA to Income from Continuing Operations Reconciliation

The following is a reconciliation of segment EBITDA to income from continuing operations before income taxes per the condensed consolidated statements of income.

	Three months ended
	March 31,
(in millions)	2017			2016
Total segment EBITDA	$	763		$	631
Reconciling items
Depreciation and amortization		(194	)		(189	)
Stock compensation		(18	)		(23	)
Net interest expense		(14	)		(28	)
Business optimization items		(3	)		(5	)
Certain foreign currency fluctuations and hedging activities		8			22
Net realized gains on Retained Shares transactions		—			3,239
Net loss on debt extinguishment		—			(101	)
Other Corporate items		(214	)		(217	)
Income from continuing operations before income taxes	$	328		$	3,329